Gaudium IVF & Women Health IPO — Listing Performance
Gaudium IVF & Women Health had a flat debut, closing within 1.59% of its issue price, on moderate subscription of 5.23x.
Gaudium IVF & Women Health IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 20-Feb-2026 |
| Listing date | 27-Feb-2026 |
| Issue size | ₹165.00 crore |
| Overall subscription | 5.23x |
| Issue price | ₹79 |
| Listing-day close | ₹80.26 (1.59%) |
| Recent market price | ₹115.27 (45.82% vs issue) |
| 52-week range | ₹69.18 – ₹133 |
| Identifiers | NSE: GAUDIUMIVF · BSE code: 544709 · ISIN: INE0P8B01020 |
Figures are compiled from public market data and refreshed when our dataset updates. Verify against BSE/NSE records before acting on them.
How the listing went
Gaudium IVF & Women Health opened for subscription on 20-Feb-2026 as a Mainboard issue raising about ₹165 crore. The shares were priced at ₹79 and made their debut on 27-Feb-2026, closing the first session at ₹80.26 — a listing-day change of 1.59%.
As of our last data refresh the stock trades around ₹115.27, 45.82% above the issue price.
Every IPO in our archive gets this same treatment: real issue data, the actual listing-day result, and where the price stands now — so you can judge how debut hype translated into outcomes. Compare more debuts on the IPO listing-performance archive or check live grey-market sentiment on the GMP board.
Gaudium IVF & Women Health IPO FAQs
What was the Gaudium IVF & Women Health IPO listing price?
Gaudium IVF & Women Health closed at ₹80.26 on its listing day (27-Feb-2026), against an issue price of ₹79 — a listing-day change of 1.59%.
How many times was the Gaudium IVF & Women Health IPO subscribed?
The issue was subscribed about 5.23 times overall.
Was the Gaudium IVF & Women Health IPO profitable for allottees?
On listing day, yes: allottees who sold at the closing price made about 1.59% over the issue price. Longer-term outcomes depend on when shares were sold.